Novateor Research Laboratories Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Novateor Research Laboratories has a total shareholder equity of ₹87.6M and total debt of ₹7.6M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are ₹104.6M and ₹17.0M respectively.
Anahtar bilgiler
8.6%
Borç/özkaynak oranı
₹7.55m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | ₹894.95k |
| Eşitlik | ₹87.63m |
| Toplam yükümlülükler | ₹16.96m |
| Toplam varlıklar | ₹104.59m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 542771's short term assets (₹75.2M) exceed its short term liabilities (₹12.0M).
Uzun Vadeli Yükümlülükler: 542771's short term assets (₹75.2M) exceed its long term liabilities (₹5.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 542771's net debt to equity ratio (7.6%) is considered satisfactory.
Borcun Azaltılması: 542771's debt to equity ratio has increased from 0.3% to 8.6% over the past 5 years.
Borç Kapsamı: 542771's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: Insufficient data to determine if 542771's interest payments on its debt are well covered by EBIT.